These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27618981)

  • 1. Deoxyinosine triphosphate induces MLH1/PMS2- and p53-dependent cell growth arrest and DNA instability in mammalian cells.
    Yoneshima Y; Abolhassani N; Iyama T; Sakumi K; Shiomi N; Mori M; Shiomi T; Noda T; Tsuchimoto D; Nakabeppu Y
    Sci Rep; 2016 Sep; 6():32849. PubMed ID: 27618981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals.
    Abolhassani N; Iyama T; Tsuchimoto D; Sakumi K; Ohno M; Behmanesh M; Nakabeppu Y
    Nucleic Acids Res; 2010 May; 38(9):2891-903. PubMed ID: 20081199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITPA protein, an enzyme that eliminates deaminated purine nucleoside triphosphates in cells.
    Sakumi K; Abolhassani N; Behmanesh M; Iyama T; Tsuchimoto D; Nakabeppu Y
    Mutat Res; 2010 Nov; 703(1):43-50. PubMed ID: 20601097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 6. The mismatch repair and meiotic recombination endonuclease Mlh1-Mlh3 is activated by polymer formation and can cleave DNA substrates in trans.
    Manhart CM; Ni X; White MA; Ortega J; Surtees JA; Alani E
    PLoS Biol; 2017 Apr; 15(4):e2001164. PubMed ID: 28453523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi mediated gene silencing of ITPA using a targeted nanocarrier: Apoptosis induction in SKBR3 cancer cells.
    Charbgoo F; Behmanesh M; Nikkhah M; Kane EG
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):888-894. PubMed ID: 28464292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mismatch repair proteins MLH1 and PMS2 can be imported to the nucleus by a classical nuclear import pathway.
    de Barros AC; Takeda AAS; Dreyer TR; Velazquez-Campoy A; Kobe B; Fontes MRM
    Biochimie; 2018 Mar; 146():87-96. PubMed ID: 29175432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUDT16 is a (deoxy)inosine diphosphatase, and its deficiency induces accumulation of single-strand breaks in nuclear DNA and growth arrest.
    Iyama T; Abolhassani N; Tsuchimoto D; Nonaka M; Nakabeppu Y
    Nucleic Acids Res; 2010 Aug; 38(14):4834-43. PubMed ID: 20385596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
    Hinrichsen I; Weßbecher IM; Huhn M; Passmann S; Zeuzem S; Plotz G; Biondi RM; Brieger A
    Mol Carcinog; 2017 Dec; 56(12):2663-2668. PubMed ID: 28767177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive screening system for damaged nucleotide-binding proteins.
    Tsuchimoto D; Iyama T; Nonaka M; Abolhassani N; Ohta E; Sakumi K; Nakabeppu Y
    Mutat Res; 2010 Nov; 703(1):37-42. PubMed ID: 20542141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics.
    Simone PD; Pavlov YI; Borgstahl GEO
    Mutat Res; 2013; 753(2):131-146. PubMed ID: 23969025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
    Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
    DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates.
    Yanamadala S; Ljungman M
    Mol Cancer Res; 2003 Aug; 1(10):747-54. PubMed ID: 12939400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human MLH1 suppresses the insertion of telomeric sequences at intra-chromosomal sites in telomerase-expressing cells.
    Jia P; Chastain M; Zou Y; Her C; Chai W
    Nucleic Acids Res; 2017 Feb; 45(3):1219-1232. PubMed ID: 28180301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring deaminated nucleotide surveillance enzyme ITPA activity with an ATP-releasing nucleotide chimera.
    Ji D; Stepchenkova EI; Cui J; Menezes MR; Pavlov YI; Kool ET
    Nucleic Acids Res; 2017 Nov; 45(20):11515-11524. PubMed ID: 29036687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.